A Cannabis Muscle-Tone Opinion Needs a Defined Measurement Method
A statement that someone’s muscle tone indicates cannabis impairment needs a defined observation and measurement method. A published perspective questions whether a subjective limb assessment can carry the same meaning as a standardized clinical evaluation.
The critique concerns what was measured
The perspective contrasts descriptions such as normal, rigid or flaccid based on an officer’s limb assessment with clinical approaches that evaluate resistance to movement using defined scales and procedures. The central issue is whether the observation has a reproducible operational definition.
This is a methodological critique, not a new controlled validation trial. It should be attributed as such. It does not establish the performance of every officer’s procedure or independently validate a replacement test.
A label needs a reproducible procedure
An interpretable muscle-tone observation should specify how the limb was assessed, what counted as an abnormal response and how the result was recorded. Without that information, two examiners may use the same word for different findings.
A numerical scale alone would not settle the cannabis question either. A proposed method would still need evidence of examiner agreement and evidence connecting its result with the particular outcome claimed.
Separate a finding from its attribution
Even a consistently observed physical sign needs a basis for attributing it to cannabis rather than another explanation. Exposure detection, a physical response and impaired driving are different conclusions.
When evaluating a report, ask what the examiner did and what the observed result can actually support. The perspective makes that measurement problem visible without supplying a cannabis-specific sensitivity, a legal rule or proof that any single clinical sign determines driving ability.
Related: How the reference specimen changes a cannabis accuracy claim.
Research cited
Journal of Studies on Alcohol and Drugs; 2025. Pseudoscience and the Detection of Marijuana-Based Impairment: We Can and Must Do Better.
